ImageneBio, Inc. Other Comprehensive Income (Loss), Net of Tax
ImageneBio, Inc. (IMA) reported Other Comprehensive Income (Loss), Net of Tax of -$34.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-24.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-07-24
- ImageneBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$34.00K.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $31.00K.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was $590.00K, a 255.42% increase year-over-year.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was -$37.00K, a 205.71% decline year-over-year.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $116.00K, a 83.78% decline from fiscal 2023.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $715.00K.
- ImageneBio, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$763.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | -$34.00K 10-Q · filed 2025-07-24 | -$3.00K derived: sum of 2 quarters · filed 2025-07-24 | |||
| 2025-03-31 | $31.00K 10-Q · filed 2025-07-24 | ||||
| 2024-12-31 | $116.00K 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | $590.00K 10-Q · filed 2024-11-07 | $553.00K derived: sum of 2 quarters · filed 2025-07-24 | $288.00K derived: sum of 3 quarters · filed 2025-07-24 | ||
| 2024-06-30 | -$37.00K 10-Q · filed 2025-07-24 | -$302.00K derived: sum of 2 quarters · filed 2025-07-24 | |||
| 2024-03-31 | -$265.00K 10-Q · filed 2025-07-24 | ||||
| 2023-12-31 | $715.00K 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $166.00K 10-Q · filed 2024-11-07 | $201.00K derived: sum of 2 quarters · filed 2024-11-07 | $473.00K derived: sum of 3 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $35.00K 10-Q · filed 2024-11-07 | $307.00K derived: sum of 2 quarters · filed 2024-11-07 | |||
| 2023-03-31 | $272.00K 10-Q · filed 2024-11-07 | ||||
| 2022-12-31 | -$763.00K 10-K · filed 2024-03-12 | $763.00K 10-K · filed 2023-03-14 | |||
| 2022-09-30 | -$77.00K 10-Q · filed 2023-11-09 | -$703.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.18M derived: sum of 3 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$626.00K 10-Q · filed 2023-11-09 | -$1.10M derived: sum of 2 quarters · filed 2023-11-09 | |||
| 2022-03-31 | -$478.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |